Search Results for: Influenza

1761 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CALR and MTNR1A calreticulin melatonin receptor 1A
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Ramelteon
  • Melatonin
  • Agomelatine
CALR and LRP1 calreticulin low density lipoprotein receptor-related protein 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Scavenging of heme from plasma
  • Visual phototransduction
  • Diseases associated with visual transduction
  • Retinoid metabolism and transport
CALR and SMARCB1 calreticulin SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Chromatin modifying enzymes
  • Chromatin organization
  • RMTs methylate histone arginines
CALR and MAPK6 calreticulin mitogen-activated protein kinase 6
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
CALR and LRIF1 calreticulin ligand dependent nuclear receptor interacting factor 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
CAMK2B and RPL11 calcium/calmodulin-dependent protein kinase II beta ribosomal protein L11
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Cellular response to heat stress
  • CREB phosphorylation through the activation of Ras
  • Trafficking of AMPA receptors
  • Interferon gamma signaling
  • HSF1-dependent transactivation
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CAMK2D and RPS4X calcium/calmodulin-dependent protein kinase II delta ribosomal protein S4, X-linked
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Cellular response to heat stress
  • CREB phosphorylation through the activation of Ras
  • Trafficking of AMPA receptors
  • Interferon gamma signaling
  • HSF1-dependent transactivation
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CAMK2D and RPS18 calcium/calmodulin-dependent protein kinase II delta ribosomal protein S18
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Cellular response to heat stress
  • CREB phosphorylation through the activation of Ras
  • Trafficking of AMPA receptors
  • Interferon gamma signaling
  • HSF1-dependent transactivation
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • CREB phosphorylation through the activation of CaMKII
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Post NMDA receptor activation events
  • Transmission across Chemical Synapses
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CANX and MBTPS1 calnexin membrane-bound transcription factor peptidase, site 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Metabolism of lipids and lipoproteins
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Antihemophilic Factor
  • Tenecteplase
CANX and HLA-A calnexin major histocompatibility complex, class I, A
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Interferon gamma signaling
  • Interferon Signaling
  • Endosomal/Vacuolar pathway
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Class I MHC mediated antigen processing & presentation
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Adaptive Immune System
  • Interferon gamma signaling
  • Interferon Signaling
  • Endosomal/Vacuolar pathway
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Class I MHC mediated antigen processing & presentation
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Adaptive Immune System
  • Antihemophilic Factor
  • Tenecteplase
CANX and CFTR calnexin cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • ABC-family proteins mediated transport
  • Antihemophilic Factor
  • Tenecteplase
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Adenosine-5\'-Diphosphate
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Phosphonoserine
  • Crofelemer
  • Ivacaftor
CANX and ITGA6 calnexin integrin, alpha 6
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Cell junction organization
  • Syndecan interactions
  • Type I hemidesmosome assembly
  • Collagen formation
  • Laminin interactions
  • Integrin cell surface interactions
  • Non-integrin membrane-ECM interactions
  • Assembly of collagen fibrils and other multimeric structures
  • Basigin interactions
  • Cell surface interactions at the vascular wall
  • Antihemophilic Factor
  • Tenecteplase
CANX and TSHR calnexin thyroid stimulating hormone receptor
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Antihemophilic Factor
  • Tenecteplase
  • Thyrotropin Alfa
CANX and SERP1 calnexin stress-associated endoplasmic reticulum protein 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • IRE1alpha activates chaperones
  • XBP1(S) activates chaperone genes
  • Unfolded Protein Response (UPR)
  • Antihemophilic Factor
  • Tenecteplase
CANX and MDM2 calnexin MDM2 proto-oncogene, E3 ubiquitin protein ligase
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Cellular Senescence
  • p53-Dependent G1/S DNA damage checkpoint
  • AKT phosphorylates targets in the cytosol
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • Stabilization of p53
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • PIP3 activates AKT signaling
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • G1/S DNA Damage Checkpoints
  • Innate Immune System
  • Signalling by NGF
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Trafficking of AMPA receptors
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • Oxidative Stress Induced Senescence
  • Cell Cycle Checkpoints
  • Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity
  • Antihemophilic Factor
  • Tenecteplase
  • Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone
  • Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone
CANX and ITGB1 calnexin integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Platelet Adhesion to exposed collagen
  • Axon guidance
  • Elastic fibre formation
  • L1CAM interactions
  • Molecules associated with elastic fibres
  • Laminin interactions
  • ECM proteoglycans
  • Fibronectin matrix formation
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Localization of the PINCH-ILK-PARVIN complex to focal adhesions
  • Cell junction organization
  • Signal transduction by L1
  • Semaphorin interactions
  • Other semaphorin interactions
  • Non-integrin membrane-ECM interactions
  • Basigin interactions
  • Cell surface interactions at the vascular wall
  • Syndecan interactions
  • CHL1 interactions
  • Integrin cell surface interactions
  • Cell-extracellular matrix interactions
  • Adaptive Immune System
  • Antihemophilic Factor
  • Tenecteplase
CANX and F8 calnexin coagulation factor VIII, procoagulant component
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Common Pathway
  • Intrinsic Pathway
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Formation of Fibrin Clot (Clotting Cascade)
  • Antihemophilic Factor
  • Tenecteplase
  • Drotrecogin alfa
  • Coagulation Factor IX
CANX and NDRG1 calnexin N-myc downstream regulated 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Antihemophilic Factor
  • Tenecteplase
CANX and ABCC2 calnexin ATP-binding cassette, sub-family C (CFTR/MRP), member 2
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • ABC-family proteins mediated transport
  • Antihemophilic Factor
  • Tenecteplase
  • Adenosine triphosphate
  • Sulfinpyrazone
CANX and PLP1 calnexin proteolipid protein 1
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • MHC class II antigen presentation
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Assembly of Viral Components at the Budding Site
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Antihemophilic Factor
  • Tenecteplase

Page 16 out of 89 pages